Skip to content

Proto Labs PRLB Stock options excluded as their inclusion would be anti-dilutive (in shares)

Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies

Kennametal logo
KennametalKMT
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$139.3M+10.4%
Gross profit$63.6M+14.2%
Operating income$9.8M+117%
Net income$8.1M+125%
EPS (diluted)$0.33+120%

Balance sheet

See full
Cash & equivalents$124.0M+49.9%
Total debt$2.6M-16.6%
Total equity$683.1M+4.0%
Total assets$778.6M+5.6%

Cash flow

See full
Operating cash flow$17.5M-4.6%
CapEx$3.5M+181%
Free cash flow$14.0M-18.2%

Valuation

See full
Market cap$1.9B+59.7%
Enterprise value$1.78B+60.4%
P/E73.7×-3.9×
P/S3.5×+1.1×

Profitability

See full
Gross margin44.9%+0.5pp
Operating margin5.6%+1.7pp
Net margin4.7%+1.6pp
FCF margin10.4%-3.1pp

Returns & leverage

See full
Return on equity3.8%+1.6pp
Debt / equity0.0×
Current ratio3.5×+0.4×

Where this comes from

Reported directly by Proto Labs in its filing.

Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.

The official record: Proto Labs’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Proto Labs's stock options excluded as their inclusion would be anti-dilutive (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Proto Labs's stock options excluded as their inclusion would be anti-dilutive (in shares)?
Proto Labs (PRLB) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 120.7K in Q1 2026.
How has Proto Labs's stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?
Proto Labs's stock options excluded as their inclusion would be anti-dilutive (in shares) decreased by 72.4% year-over-year, from 436.7K to 120.7K.
What is the long-term trend for Proto Labs's stock options excluded as their inclusion would be anti-dilutive (in shares)?
Over 3 years (2022 to 2025), Proto Labs's stock options excluded as their inclusion would be anti-dilutive (in shares) has grown at a 17.4% compound annual growth rate (CAGR), from 862.4K to 1.4M.
What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
The number of potential common shares from stock options or other equity instruments that are excluded from the diluted earnings per share calculation because their inclusion would increase earnings per share. This indicates the volume of underwater or non-dilutive equity awards currently outstanding.